Intrafollicular levels of matrix metalloproteinases-2 and -9 in patients with polycystic ovaries are not associated with pregnancy rate during IVF cycle

In Vivo. 2009 Jan-Feb;23(1):89-92.

Abstract

This study aimed to detect the levels of matrix metalloproteinases (MMP)-2 and -9, using enzyme-linked immunosorbent assays, in the follicular fluid of 35 patients with polycystic ovaries, compare them with the levels found in 35 normally ovulating women enrolled in their first in vitro fertilization (IVF) cycle and then correlate them with pregnancy rates in these two groups. Levels of MMP-9 were found significantly increased in women with polycystic ovaries when compared with the controls, while MMP-2 levels were higher in women with polycystic ovaries without reaching statistical significance. The two groups did not differ in age, in the number of embryos transferred or in pregnancy rates. In conclusion, the results indicated an increased gelatinolytic activity in patients with polycystic ovaries after ovarian stimulation for IVF treatment without detecting any association between levels of MMP-2 and 9 and IVF pregnancy rates.

MeSH terms

  • Adult
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Fertilization in Vitro*
  • Follicular Fluid / chemistry
  • Follicular Fluid / enzymology*
  • Humans
  • Matrix Metalloproteinase 2 / metabolism*
  • Matrix Metalloproteinase 9 / metabolism*
  • Polycystic Ovary Syndrome / enzymology*
  • Polycystic Ovary Syndrome / pathology
  • Pregnancy
  • Pregnancy Rate*

Substances

  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9